TapewireFind a company

person · Reporting owner

Ball Robert Joseph

Disclosed activity across 1 company

Tapewire entity
50513
SEC CIK
0002070664

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
SHOULDER INNOVATIONS, INC.SI · Entity 5607Director · CEO & Executive ChairmanSeptember 14, 2026September 15, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

SHOULDER INNOVATIONS, INC.

Report date September 14, 2026 · Filed September 15, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect390,999 Reported balance After 2026-09-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-09-14 · Exercise / conversion · Acquired 89,233 · Balance 390,999

F1: Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan.

Common StockSEC Table I · non-derivativeDirect380,824 Reported balance After 2026-09-14 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2026-09-14 · Sale · Disposed 10,175 · Balance 380,824

F2: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.22 to $18.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The shares of Common Stock were sold solely to cover the exercise price in connection with the exercise of the stock option.

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.10 · Expires 2030-12-16Direct92,143 Reported balance After 2026-09-14 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-09-14 · Exercise / conversion · Disposed 89,233 · Balance 92,143

F3: The stock option is fully vested and currently exercisable.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan.

F2: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.22 to $18.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The shares of Common Stock were sold solely to cover the exercise price in connection with the exercise of the stock option.

F3: The stock option is fully vested and currently exercisable.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 14, 2026 Filed Sep 15, 2026 00:23 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionStock Option · Derivative 89,233 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0002070664-26-000006 · wk-form4_1789431783.xml · derivative · entry 3

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,143

Underlying: Common Stock · 89,233 shares

Expires 2030-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

Read SEC document
September 14, 2026 Filed Sep 15, 2026 00:23 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 SaleCommon Stock 10,175 $18.45 $187,706.37
Disclosure

SEC source: 0002070664-26-000006 · wk-form4_1789431783.xml · nonDerivative · entry 2

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,824

F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.22 to $18.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The shares of Common Stock were sold solely to cover the exercise price in connection with the exercise of the stock option.

Read SEC document
September 14, 2026 Filed Sep 15, 2026 00:23 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionCommon Stock 89,233 $2.10 $187,282.22
Disclosure

SEC source: 0002070664-26-000006 · wk-form4_1789431783.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 390,999

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan.

Read SEC document
April 30, 2026 Filed Apr 30, 2026 20:33 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0002070664-26-000005 · wk-form4_1777581232.xml · derivative · entry 2

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 309,756

Underlying: Common Stock · 10,000 shares

Expires 2033-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested as to one-fourth of the underlying shares on May 17, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter.

Read SEC document
April 30, 2026 Filed Apr 30, 2026 20:33 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionCommon Stock 10,000 $2.48 $24,804.00
Disclosure

SEC source: 0002070664-26-000005 · wk-form4_1777581232.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,018

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes the following shares received without consideration as in-kind distributions: (i) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (ii) 6,752 shares from Genesis Investment Holdings. In prior reports, the reporting person reported beneficial ownership of 278,866 shares of Shoulder Innovations common stock held directly.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 21:31 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 PurchaseCommon Stock 2,200 $15.18 $33,392.04
Disclosure

SEC source: 0002070664-26-000004 · wk-form4_1773783067.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,866

F1 · price: The price reported in Column 4 is a weighted average purchase price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $14.80 to $15.50, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth herein.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 21:24 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionStock Option · Derivative 2,062 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · derivative · entry 4

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,376

Underlying: Common Stock · 2,062 shares

Expires 2030-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 21:24 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · derivative · entry 3

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,756

Underlying: Common Stock · 10,000 shares

Expires 2033-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested as to one-fourth of the underlying shares on May 17, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 21:24 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionCommon Stock 2,062 $2.10 $4,327.73
Disclosure

SEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · nonDerivative · entry 2

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 21:24 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 Exercise / conversionCommon Stock 10,000 $2.48 $24,804.00
Disclosure

SEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes the following shares received without consideration as in-kind distributions: (i) 110,331 shares from Genesis Investment Holdings; (ii) 7,859 shares from cultivate(MD) Capital Accelerator Fund, L.P.; (iii) 6,948 shares from Cultivate MD Capital Fund I, LLC; and (iv) 19,348 shares from Cultivate MD Capital Fund II, LP. In prior reports, the reporting person reported beneficial ownership of 120,118 shares of Shoulder Innovations common stock held directly.

Read SEC document
January 30, 2026 Filed Feb 3, 2026 21:35 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 GrantStock Option · Derivative 265,351 $0.00 Strike: $14.16 $0.00
Disclosure

SEC source: 0002070664-26-000002 · wk-form4_1770154525.xml · derivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,351

Underlying: Common Stock · 265,351 shares

Expires 2033-01-30

F1 · derivative.exercise_date: The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027.

Read SEC document
December 31, 2025 Filed Jan 8, 2026 21:57 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 GrantCommon Stock 1,661 $12.16 $20,197.76
Disclosure

SEC source: 0002070664-26-000001 · wk-form4_1767909450.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,118

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2025 Employee Stock Purchase Plan ("ESPP") .

F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2025.

Read SEC document
December 12, 2025 Filed Dec 15, 2025 21:51 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 PurchaseCommon Stock 3,900 $14.89 $58,075.29
Disclosure

SEC source: 0001628280-25-057067 · wk-form4_1765835502.xml · nonDerivative · entry 2

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,457

F2 · price: The price reported in Column 4 is a weighted average purchase price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $14.60 to $15.26, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth herein.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:51 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 PurchaseCommon Stock 3,300 $14.83 $48,934.05
Disclosure

SEC source: 0001628280-25-057067 · wk-form4_1765835502.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,557

F1 · price: The price reported in Column 4 is a weighted average purchase price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $14.56 to $15.16, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth herein.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 20:15 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 PurchaseCommon Stock 6,000 $15.49 $92,945.40
Disclosure

SEC source: 0001493152-25-013475 · ownership.xml · nonDerivative · entry 2

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,259

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.9196 to $15.815. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:15 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 PurchaseCommon Stock 2,000 $14.90 $29,809.60
Disclosure

SEC source: 0001493152-25-013475 · ownership.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,259

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.8096 to $15.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:05 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 ConversionSeries E Convertible Preferred Stock · Derivative 146,459 Not disclosed Not disclosed
Disclosure

SEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 6

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,676 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:05 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 ConversionSeries D Convertible Preferred Stock · Derivative 706,572 Not disclosed Not disclosed
Disclosure

SEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 5

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,032 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:05 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 ConversionSeries B Convertible Preferred Stock · Derivative 387,346 Not disclosed Not disclosed
Disclosure

SEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 4

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,301 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:05 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 ConversionSeries A Convertible Preferred Stock · Derivative 176,086 Not disclosed Not disclosed
Disclosure

SEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 3

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,228 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:05 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 ConversionSeries Seed Convertible Preferred Stock · Derivative 222,304 Not disclosed Not disclosed
Disclosure

SEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 2

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,651 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:05 UTC SHOULDER INNOVATIONS, INC. SI · Entity 5607 ConversionCommon Stock 85,888 Not disclosed Not disclosed
Disclosure

SEC source: 0001641172-25-022242 · ownership.xml · nonDerivative · entry 1

Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.